Original Research

Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year After Standard Treatment

Yu C, Jiang L, Yang D, Dong X, Yu R, Yu H

OncoTargets and Therapy 2022, 15:1221-1228

Published Date: 17 October 2022